Reproductive abnormalities in human insulin-like growth factor-binding protein-1 transgenic male mice. 2004

Pascal Froment, and Christophe Staub, and Stéphanie Hembert, and Claudine Pisselet, and Michèle Magistrini, and Bernadette Delaleu, and Danielle Seurin, and Jon E Levine, and Larry Johnson, and Michel Binoux, and Philippe Monget
Physiologie de la Reproduction et des Comportements, Unité Mixte de Recherche 6073, Institut National de la Recherche Agronomique-Centre National de la Recherche Scientifique-Université F. Rabelais de Tours, 37380 Nouzilly, France.

Adult transgenic mice overexpressing human insulin-like growth factor-binding protein-1 in the liver present reproductive abnormalities in both sexes. In the present work, we have investigated the mechanisms responsible for limiting breeding capacity in these transgenic male mice. Homozygous adult transgenic male mice (3-6 months old) exhibited irregular copulatory behavior and a reduction of the number of pregnancies per female as well as of litter size per pregnancy. Genital tract weight, more specifically epididymal and seminal vesicle weights, were reduced by 45% in homozygous transgenic vs. nontransgenic mice. Homozygous transgenic mice exhibited a 30% reduction of the length of seminiferous tubules (P = 0.007), a 30% decrease in daily sperm production per testis (P = 0.019), and a 50% decrease in the number of spermatozoa in testis (P = 0.037), associated with morphological abnormalities of the sperm heads leading to an approximately 50% reduction of fertilized two-cell eggs (P = 0.002) and of implanted embryos on d 5.5 after mating (P = 0.004). The round spermatids also appeared altered in their morphology. In addition, Leydig cells in homozygous transgenic mice exhibited an altered appearance, with a 1.8-fold increase in lipid droplets in their cytoplasm (P < 0.001). Moreover, the concentration of 3beta-hydroxysteroid dehydrogenase was 66% lower in testis from transgenics compared with those from normal mice (P = 0.01), leading to a tendency toward lower plasma testosterone levels (P = 0.1). Interestingly, LH concentrations were increased by 40% in transgenic pituitary extracts (P = 0.02), and basal LH secretion by pituitary explants in vitro was increased by 60% in homozygous transgenic vs. normal mice (P = 0.04), suggesting an alteration of LH pulsatile secretion in vivo. In conclusion, these data suggest that the breeding impairment of human insulin-like growth factor-binding protein-1 transgenic males is due at least in part to an alteration of the process of spermatogenesis, leading to a diminution of sperm production and of its quality. Minor impairment of steroidogenesis may also contribute to the reduced reproductive capacity of these animals. Our observations are consistent with the idea that normal spermatogenesis and perhaps also steroidogenesis are dependent on the actions of sufficient concentrations of unbound IGF-I.

UI MeSH Term Description Entries
D007248 Infertility, Male The inability of the male to effect FERTILIZATION of an OVUM after a specified period of unprotected intercourse. Male sterility is permanent infertility. Sterility, Male,Sub-Fertility, Male,Subfertility, Male,Male Infertility,Male Sterility,Male Sub-Fertility,Male Subfertility,Sub Fertility, Male
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008297 Male Males
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010902 Pituitary Gland A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk which is called the INFUNDIBULUM. Hypophysis,Hypothalamus, Infundibular,Infundibular Stalk,Infundibular Stem,Infundibulum (Hypophysis),Infundibulum, Hypophyseal,Pituitary Stalk,Hypophyseal Infundibulum,Hypophyseal Stalk,Hypophysis Cerebri,Infundibulum,Cerebri, Hypophysis,Cerebrus, Hypophysis,Gland, Pituitary,Glands, Pituitary,Hypophyseal Stalks,Hypophyses,Hypophysis Cerebrus,Infundibular Hypothalamus,Infundibular Stalks,Infundibulums,Pituitary Glands,Pituitary Stalks,Stalk, Hypophyseal,Stalk, Infundibular,Stalks, Hypophyseal,Stalks, Infundibular
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D005298 Fertility The capacity to conceive or to induce conception. It may refer to either the male or female. Fecundity,Below Replacement Fertility,Differential Fertility,Fecundability,Fertility Determinants,Fertility Incentives,Fertility Preferences,Fertility, Below Replacement,Marital Fertility,Natural Fertility,Subfecundity,World Fertility Survey,Determinant, Fertility,Determinants, Fertility,Fertility Determinant,Fertility Incentive,Fertility Preference,Fertility Survey, World,Fertility Surveys, World,Fertility, Differential,Fertility, Marital,Fertility, Natural,Preference, Fertility,Preferences, Fertility,Survey, World Fertility,Surveys, World Fertility,World Fertility Surveys
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000728 Androgens Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. Androgen,Androgen Receptor Agonist,Androgen Effect,Androgen Effects,Androgen Receptor Agonists,Androgenic Agents,Androgenic Compounds,Agents, Androgenic,Agonist, Androgen Receptor,Agonists, Androgen Receptor,Compounds, Androgenic,Effect, Androgen,Effects, Androgen,Receptor Agonist, Androgen,Receptor Agonists, Androgen

Related Publications

Pascal Froment, and Christophe Staub, and Stéphanie Hembert, and Claudine Pisselet, and Michèle Magistrini, and Bernadette Delaleu, and Danielle Seurin, and Jon E Levine, and Larry Johnson, and Michel Binoux, and Philippe Monget
June 2000, Kidney international,
Pascal Froment, and Christophe Staub, and Stéphanie Hembert, and Claudine Pisselet, and Michèle Magistrini, and Bernadette Delaleu, and Danielle Seurin, and Jon E Levine, and Larry Johnson, and Michel Binoux, and Philippe Monget
January 1997, Biology of reproduction,
Pascal Froment, and Christophe Staub, and Stéphanie Hembert, and Claudine Pisselet, and Michèle Magistrini, and Bernadette Delaleu, and Danielle Seurin, and Jon E Levine, and Larry Johnson, and Michel Binoux, and Philippe Monget
April 1999, Journal of hepatology,
Pascal Froment, and Christophe Staub, and Stéphanie Hembert, and Claudine Pisselet, and Michèle Magistrini, and Bernadette Delaleu, and Danielle Seurin, and Jon E Levine, and Larry Johnson, and Michel Binoux, and Philippe Monget
September 1999, The Journal of endocrinology,
Pascal Froment, and Christophe Staub, and Stéphanie Hembert, and Claudine Pisselet, and Michèle Magistrini, and Bernadette Delaleu, and Danielle Seurin, and Jon E Levine, and Larry Johnson, and Michel Binoux, and Philippe Monget
July 2000, Pediatric nephrology (Berlin, Germany),
Pascal Froment, and Christophe Staub, and Stéphanie Hembert, and Claudine Pisselet, and Michèle Magistrini, and Bernadette Delaleu, and Danielle Seurin, and Jon E Levine, and Larry Johnson, and Michel Binoux, and Philippe Monget
September 1995, Endocrinology,
Pascal Froment, and Christophe Staub, and Stéphanie Hembert, and Claudine Pisselet, and Michèle Magistrini, and Bernadette Delaleu, and Danielle Seurin, and Jon E Levine, and Larry Johnson, and Michel Binoux, and Philippe Monget
October 1996, The Journal of clinical investigation,
Pascal Froment, and Christophe Staub, and Stéphanie Hembert, and Claudine Pisselet, and Michèle Magistrini, and Bernadette Delaleu, and Danielle Seurin, and Jon E Levine, and Larry Johnson, and Michel Binoux, and Philippe Monget
May 2002, Endocrinology,
Pascal Froment, and Christophe Staub, and Stéphanie Hembert, and Claudine Pisselet, and Michèle Magistrini, and Bernadette Delaleu, and Danielle Seurin, and Jon E Levine, and Larry Johnson, and Michel Binoux, and Philippe Monget
December 1995, Journal of molecular endocrinology,
Pascal Froment, and Christophe Staub, and Stéphanie Hembert, and Claudine Pisselet, and Michèle Magistrini, and Bernadette Delaleu, and Danielle Seurin, and Jon E Levine, and Larry Johnson, and Michel Binoux, and Philippe Monget
May 2004, Endocrinology,
Copied contents to your clipboard!